Decrease in Mycobacterium tuberculosis specific immune responses in patients with untreated psoriasis living in a tuberculosis endemic area

Archives of Dermatological Research

Volumn 302, Issue 4, 2010, Pages 255-262

  Silva, Léia C R ^a   Silveira, Guilherme G ^a   Arnone, Marcelo ^a   Romiti, Ricardo ^a   Geluk, Annemiek ^b   Franken, Kees C L M ^b   Duarte, Alberto José Da Silva ^a   Takahashi, Maria Denise Fonseca ^a   Benard, Gil ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

85B antigen; ESAT 6; Psoriasis; Tuberculin skin test; Tuberculosis

Indexed keywords

BACTERIAL PROTEIN; EARLY SECRETORY ANTIGENIC TARGET 6; GAMMA INTERFERON; INTERLEUKIN 10; MYCOBACTERIUM ANTIGEN; PHYTOHEMAGGLUTININ; PROTEIN AG85B; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BACTERIAL IMMUNITY; CELL ACTIVITY; CELL SECRETION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE SEVERITY; EFFECTOR CELL; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FALSE NEGATIVE RESULT; FEMALE; HUMAN; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; MALE; MEMORY T LYMPHOCYTE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; POSTPRIMARY TUBERCULOSIS; PRIORITY JOURNAL; PSORIASIS; T LYMPHOCYTE; TUBERCULIN TEST; TUBERCULOSIS;

EID: 77952243893     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00403-009-0982-2     Document Type: Article

References (34)

1. S Arend A Geluk KE van Meijgaarden JT van Dissel P Andersen M Theisen THM Ottenhoff 2000 Antigenic equivalence of human T-cell responses to Mycobacterium tuberculosis-specific RD1-encoded protein antigens ESAT-6 and culture filtrate protein 10 and to mixtures of synthetic peptides Infect Immun 68 3314 3321 10.1128/IAI.68.6.3314-3321.2000 10.1128/IAI.68.6.3314-3321.2000 1:CAS:528:DC%2BD3cXjsFyqu7Y%3D 10816479 (Pubitemid 30340425)
2. ML Bay A Lehrer A Bressanelli J Morini O Bottasso J Stanford 1998 Psoriasis patients have T-cells with reduced responsiveness to common mycobacterial antigens FEMS Immunol Med Microbiol 21 65 70 10.1111/j.1574-695X. 1998.tb01150.x 10.1111/j.1574-695X.1998.tb01150.x 1:CAS:528:DyaK1cXjsVehu7c%3D 9657322
3. A Castelo Filho AL Kritski AW Barreto, et al. 2004 II Consenso Brasileiro de Tuberculose: Diretrizes Brasileiras para Tuberculose J Bras Pneumol 30 24 35 10.1590/S1806-37132004000700002 10.1590/S1806-37132004000700002
4. K Ekström Smedby CM Vajdic M Falster, et al. 2008 Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium Blood 111 4029 4038 10.1182/blood-2007-10-119974 10.1182/blood-2007-10-119974 18263783
5. P Emery GS Panayi KI Welsh BC Cole 1985 Relationship of HLA-DR4 to defective cellular immunity in rheumatoid arthritis using PPD, and mycoplasma and lectin mitogens J Rheumatol 12 859 864 1:STN:280:DyaL287hsFWlug%3D%3D 3878876
6. G Ferrara M Losi R D'Amico, et al. 2006 Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study Lancet 367 1328 10.1016/S0140-6736(06)68579-6 10.1016/S0140-6736(06)68579-6 1:CAS:528:DC%2BD28Xjsl2ktL0%3D 16631911
7. VRMS Ferrari FL Dulley JCA Barros AJS Duarte G Benard 2006 Distinct patterns of regeneration of central memory, effector memory and effector TCD8+ cell subsets after different hematopoietic cell transplant types: possible influence in the recovery of anti-cytomegalovirus immune response and risk for its reactivation Clin Immunol 119 261 271 10.1016/j.clim.2005.12.001 10.1016/j.clim.2005.12.001 1:CAS:528:DC%2BD28XksFymsb8%3D 16426894 (Pubitemid 44262100)
8. A Geluk KE van Meijgaarden KL Franken, et al. 2002 Identification and characterization of the ESAT-6 homologue of Mycobacterium leprae and T-cell cross-reactivity with Mycobacterium tuberculosis Infect Immun 70 2544 2548 10.1128/IAI.70.5.2544-2548.2002 10.1128/IAI.70.5.2544-2548.2002 1:CAS:528:DC%2BD38XjtFKnsro%3D 11953394 (Pubitemid 34408399)
9. E Girardi D Goletti G Ippolito 2007 Should individuals who are tuberculin skin test negative and positive to RD1-IFN-gamma assay receive preventive therapy? Am J Respir Crit Care Med 175 198 199 17200510
10. CE Griffiths JN Barker 2007 Pathogenesis and clinical features of psoriasis Lancet 370 263 271 10.1016/S0140-6736(07)61128-3 10.1016/S0140- 6736(07)61128-3 1:CAS:528:DC%2BD2sXnvF2gs7w%3D 17658397 (Pubitemid 47069537)
11. PC Hill RH Brookes A Fox D Jackson-Sillah MD Lugos DJ Jeffries SA Donkor RA Adegbola KP McAdam 2006 Surprisingly high specificity of the PPD skin test for M. tuberculosis infection from recent exposure in the Gambia Plos One 20 1e68
12. PC Hill DJ Jackson-Sillah A Fox, et al. 2008 Incidence of tuberculosis and the predictive value of ELISPOT and Mantoux tests in Gambian case contacts PLoS One 3 1379 10.1371/journal.pone.0001379 10.1371/journal.pone.0001379 (Pubitemid 351223138)
13. DF Hoft S Worku B Kampmann, et al. 2002 Investigation of the relationships between immune-mediated inhibition of mycobacterial growth and other potential surrogate markers of protective Mycobacterium tuberculosis immunity J Infect Dis 186 1448 1457 10.1086/344359 10.1086/344359 1:CAS:528:DC%2BD38XpsVWjtLo%3D 12404160 (Pubitemid 35286112)
14. RE Huebner MF Schein JB Bass Jr 1993 The tuberculin skin test Clin Infect Dis 17 968 975 1:STN:280:DyaK2c7lsVWgsA%3D%3D 8110954
15. M Jacobs D Togbe C Fremond, et al. 2007 Tumor necrosis factor is critical to control tuberculosis infection Microbes Infect 9 623 628 10.1016/j.micinf.2007.02.002 10.1016/j.micinf.2007.02.002 1:CAS:528: DC%2BD2sXksVyit7Y%3D 17409008 (Pubitemid 46628779)
16. DJ Jeffries PC Hill M Lugos DJ Jackson-Sillah RA Adegbola RH Brookes 2006 Identifying ELISPOT and skin test cut-offs for diagnosis of Mycobacterium tuberculosis infection in the Gambia Int J Tuberc Lung Dis 10 192 198 1:STN:280:DC%2BD287ht1Cgsg%3D%3D 16499260
17. YA Kang HW Lee HI Yoon B Cho SK Han YS Shim JJ Yim 2005 Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country JAMA 293 2756 2761 10.1001/jama.293.22.2756 10.1001/jama.293.22.2756 1:CAS:528:DC%2BD2MXltVCgurY%3D 15941805 (Pubitemid 40965087)
18. JG Krueger A Bowcock 2005 Psoriasis pathophysiology: current concepts of pathogenesis Ann Rheum Dis 64 30 36 10.1136/ard.2004.031120 10.1136/ard.2004. 031120 (Pubitemid 40288517)
19. A Lalvani R Brookes RJ Wilkinson AS Malin AA Pathan P Andersen H Dockrell G Pasvol AV Hill 1998 Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis Proc Natl Acad Sci USA 95 270 275 10.1073/pnas.95.1.270 10.1073/pnas.95.1.270 1:CAS:528: DyaK1cXjtl2isA%3D%3D 9419365 (Pubitemid 28103943)
20. P Launois R DeLeys MN Niang, et al. 1994 T-cell-epitope mapping of the major secreted mycobacterial antigen Ag85A in tuberculosis and leprosy Infect Immun 62 3679 3687 1:CAS:528:DyaK2cXmtVeis74%3D 7520418
21. B Lindegård 1986 Diseases associated with psoriasis in a general population of 159,200 middle-aged, urban, native Swedes Dermatologica 172 298 304 10.1159/000249365 3089849
22. A Marchant A Amedei A Azzurri, et al. 2001 Polarization of PPD-specific T-cell response of patients with tuberculosis from Th0 to Th1 profile after successful antimycobacterial therapy or in vitro conditioning with interferon-α or interleukin-12 Am J Respir Cell Mol Biol 24 187 194 1:CAS:528:DC%2BD3MXhsVOktrw%3D 11159053
23. M Mendonça MM Tanji LC Silva GG Silveira SC Oliveira AJ Duarte G Benard 2007 Deficient in vitro anti-mycobacterial immunity despite successful long-term highly active antiretroviral therapy in HIV-infected patients with past history of tuberculosis infection or disease Clin Immunol 125 60 66 10.1016/j.clim.2007.06.002 10.1016/j.clim.2007.06.002 17631053 (Pubitemid 47376923)
24. L Paimela EA Johansson-Stephansson S Koskimies M Leirisalo-Repo 1990 Depressed cutaneous cell-mediated immunity in early rheumatoid arthritis Clin Exp Rheumatol 8 433 437 1:STN:280:DyaK3M%2FosFShtQ%3D%3D 2261703
25. CB Pereira M Palaci OHM Leite AJS Duarte G Benard 2004 Monocyte cytokine secretion in patients with pulmonary tuberculosis differs from that of healthy infected subjects and correlates with clinical manifestations Microbes Infect 6 25 33 10.1016/j.micinf.2003.10.007 10.1016/j.micinf.2003.10.007 1:CAS:528:DC%2BD2cXltFahtg%3D%3D 14738890 (Pubitemid 38114818)
26. D Ponce de Leon E Acevedo-Vasquez A Sanchez-Torres, et al. 2005 Attenuated response to purified protein derivative in patients with rheumatoid arthritis: study in a population with a high prevalence of tuberculosis Ann Rheum Dis 64 1360 1361 10.1136/ard.2004.029041 10.1136/ard.2004.029041 1:CAS:528:DC%2BD2MXhtVChu7zE 16100342 (Pubitemid 41206259)
27. F Ponchel AW Morgan SJ Bingham, et al. 2002 Dysregulated lymphocyte proliferation and differentiation in patients with rheumatoid arthritis Blood 100 4550 4556 10.1182/blood-2002-03-0671 10.1182/blood-2002-03-0671 1:CAS:528:DC%2BD38XpsFCqtrw%3D 12393721 (Pubitemid 35429697)
28. A Raval G Akhavan-Toyserkani A Brinker M Avigan 2007 Brief communication: characteristics of spontaneous cases of tuberculosis associated with infliximab Ann Intern Med 147 699 702 18025446
29. L Richeldi 2006 An update on the diagnosis of tuberculosis infection Am J Respir Crit Care Med 174 736 742 10.1164/rccm.200509-1516PP 10.1164/rccm.200509-1516PP 16799073 (Pubitemid 44511654)
30. CH Smith AV Anstey JN Barker British Association of Dermatologists 2005 British Association of Dermatologists guidelines for use of biological interventions in psoriasis 2005 Br J Dermatol 153 486 497 10.1111/j.1365-2133. 2005.06893.x 10.1111/j.1365-2133.2005.06893.x 1:STN:280:DC%2BD2MvltlaksQ%3D%3D 16120132 (Pubitemid 41248202)
31. Souza TNL Avaliação da prevalência da infecção por Mycobacterium tuberculosis entre os profissionais de saúde do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. São Paulo, 1999 Dissertação (Mestrado) - Departamento de Doenças Infecciosas e Parasitárias, Faculdade de Medicina, Universidade de São Paulo
32. H Sugiyama R Gyulai E Toichi E Garaczi S Shimada SR Stevens TS McCormick KD Cooper 2005 Dysfunctional blood and target tissue CD4+CD25 high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation J Immunol 174 164 173 1:CAS:528:DC%2BD2cXhtFaiur%2FF 15611238
33. J Tzu F Kerdel 2008 From conventional to cutting edge: the new era of biologics in treatment of psoriasis Dermatol Ther 21 131 141 10.1111/j.1529-8019.2008.00180.x 10.1111/j.1529-8019.2008.00180.x 18394087 (Pubitemid 351499216)
34. RS Wallis M Broder J Wong A Lee L Hoq 2005 Reactivation of latent granulomatous infections by infliximab Clin Infect Dis 41 194 198 10.1086/429996 10.1086/429996 (Pubitemid 41022090)